UBS Group’s Corteva CTVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $242M | Sell |
2,861,946
-36,472
| -1% | -$2.93M | 0.03% | 563 |
|
|
2026
Q1 | $243M | Buy |
2,898,418
+873,278
| +43% | +$65.8M | 0.04% | 528 |
|
|
2025
Q4 | $136M | Sell |
2,025,140
-704,768
| -26% | -$45.6M | 0.02% | 800 |
|
|
2025
Q3 | $185M | Sell |
2,729,908
-317,650
| -10% | -$23M | 0.03% | 630 |
|
|
2025
Q2 | $227M | Sell |
3,047,558
-152,701
| -5% | -$10.2M | 0.04% | 482 |
|
|
2025
Q1 | $201M | Sell |
3,200,259
-421,082
| -12% | -$26M | 0.04% | 500 |
|
|
2024
Q4 | $206M | Buy |
3,621,341
+1,363,366
| +60% | +$80.6M | 0.04% | 495 |
|
|
2024
Q3 | $133M | Sell |
2,257,975
-20,894
| -0.9% | -$1.14M | 0.03% | 588 |
|
|
2024
Q2 | $123M | Buy |
2,278,869
+326,579
| +17% | +$18M | 0.03% | 543 |
|
|
2024
Q1 | $113M | Buy |
1,952,290
+212,502
| +12% | +$11M | 0.03% | 596 |
|
|
2023
Q4 | $83.4M | Buy |
1,739,788
+235,385
| +16% | +$11.2M | 0.03% | 672 |
|
|
2023
Q3 | $77M | Sell |
1,504,403
-220,924
| -13% | -$11.7M | 0.03% | 608 |
|
|
2023
Q2 | $98.9M | Sell |
1,725,327
-116,433
| -6% | -$6.8M | 0.03% | 502 |
|
|
2023
Q1 | $111M | Buy |
1,841,760
+7,404
| +0.4% | +$452K | 0.04% | 421 |
|
|
2022
Q4 | $108M | Buy |
1,834,356
+365,211
| +25% | +$23.1M | 0.04% | 462 |
|
|
2022
Q3 | $84M | Sell |
1,469,145
-51,978
| -3% | -$3.03M | 0.04% | 488 |
|
|
2022
Q2 | $82.4M | Sell |
1,521,123
-18,160
| -1% | -$1.05M | 0.03% | 513 |
|
|
2022
Q1 | $88.5M | Sell |
1,539,283
-174,699
| -10% | -$8.93M | 0.03% | 562 |
|
|
2021
Q4 | $81M | Sell |
1,713,982
-330,226
| -16% | -$15M | 0.02% | 695 |
|
|
2021
Q3 | $86M | Buy |
2,044,208
+696,206
| +52% | +$30.1M | 0.03% | 594 |
|
|
2021
Q2 | $59.8M | Sell |
1,348,002
-219,072
| -14% | -$10.1M | 0.02% | 751 |
|
|
2021
Q1 | $73.1M | Sell |
1,567,074
-381,611
| -20% | -$16.9M | 0.02% | 641 |
|
|
2020
Q4 | $75.5M | Buy |
1,948,685
+977,823
| +101% | +$34.9M | 0.03% | 584 |
|
|
2020
Q3 | $28M | Sell |
970,862
-4,022,740
| -81% | -$113M | 0.01% | 960 |
|
|
2020
Q2 | $134M | Buy |
4,993,602
+154,225
| +3% | +$4.01M | 0.06% | 309 |
|
|
2020
Q1 | $114M | Buy |
4,839,377
+1,720,805
| +55% | +$47.3M | 0.05% | 317 |
|
|
2019
Q4 | $92.2M | Sell |
3,118,572
-2,024,702
| -39% | -$53.6M | 0.03% | 478 |
|
|
2019
Q3 | $144M | Buy |
5,143,274
+2,309,747
| +82% | +$66.8M | 0.06% | 311 |
|
|
2019
Q2 | $83.8M | Buy |
+2,833,527
| New | +$76.2M | 0.03% | 452 |
|
Other funds holding CTVA
UBS Group's CTVA Position: Q2 2026 in Review
UBS Group reduced its Corteva (CTVA) stake by 1.3% in Q2 2026, selling an estimated $2.93M and leaving 2,861,946 shares worth $242M. The position accounts for 0.03% of the portfolio, ranked #563.
UBS Group first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $243M in Q1 2026. 1,499 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.
- UBS Group held 2,861,946 shares of Corteva worth $242M as of Q2 2026.
- UBS Group sold 36,472 Corteva shares in Q2 2026, an estimated $2.93M.
- Corteva made up 0.03% of UBS Group's portfolio in Q2 2026, its #563 holding.
- UBS Group first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
- UBS Group's Corteva position peaked at $243M in Q1 2026.
- 1,499 funds tracked by Wall St. Rank held Corteva as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.